跳至主要内容
临床试验/NCT06850116
NCT06850116进行中(未招募)不适用

Analysis of Immediate Urinary Continence Predictors After Retzius-sparing Robot-assisted Radical Prostatectomy: A Single-center Retrospective Clinical Study

First Affiliated Hospital of Fujian Medical University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年1月1日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
400
试验地点
1
主要终点
rate of continence

研究概览

简要总结

This study is a retrospective, single-center clinical trial. It aims to retrospectively analyze the immediate postoperative urinary continence recovery in prostate cancer patients who underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' center. Based on the general conditions of patients, relevant perioperative clinical indicators, and parameters related to the sphincter and prostate gland measured by MRI, it explores the influencing factors of immediate urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in prostate cancer patients and constructs a relevant prediction model, thereby providing clinical guidance value for predicting immediate postoperative urinary continence recovery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Male
接受健康志愿者

入选标准

  • Prostate cancer diagnosed by prostate biopsy and underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' hospital.
  • Received plain and contrast-enhanced pelvic or prostate MRI examinations before surgery.
  • Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and
  • Complete clinicopathological data.
  • In good general condition, without infections, autoimmune diseases, hematological diseases or other malignant tumors.
  • Complete postoperative follow-up data, with a postoperative follow-up time of no less than 6 months.

排除标准

  • The patient has surgical contraindications.
  • The patient has contraindications for MRI examination.
  • Preoperative presence of congenital urinary system malformations, urinary incontinence or severe lower urinary tract symptoms, and with a history of urinary catheter or previous transurethral resection of the prostate (TURP) surgery.
  • Having received neoadjuvant treatments that may affect the results of this study, such as radiotherapy or hormonal therapy.
  • The patient has other concurrent malignant tumors.
  • The patient has delayed extubation (> 14 days).
  • The patient's clinical, imaging and pathological data are incomplete or the patient is lost to follow-up.

结局指标

主要结局

rate of continence

时间窗: rate of the preservation of urinary control function at 1 week after postoperative removal of the urinary catheter status

Time Frame: 1 week after postoperative removal of the urinary catheter

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验